tiprankstipranks
AbbVie (GB:0QCV)
LSE:0QCV
Holding GB:0QCV?
Track your performance easily

AbbVie (0QCV) Technical Analysis

8 Followers

Technical Sentiment

Overall Consensus
Neutral
9Bullish
6Neutral
7Bearish
Technical Analysis Consensus
Buy
3Bullish
6Neutral
1Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
AbbVie’s (0QCV) Moving Averages Convergence Divergence (MACD) indicator is -5.64, suggesting AbbVie is a Buy.
AbbVie’s (0QCV) 20-Day exponential moving average is 179.92, while AbbVie’s (0QCV) share price is $177.828, making it a Sell.
AbbVie’s (0QCV) 50-Day exponential moving average is 185.21, while AbbVie’s (0QCV) share price is $177.828, making it a Sell.

AbbVie (0QCV) Pivot Points

Nov 26, 2024, 08:46 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
167.29
169.84
173.61
176.16
179.93
182.48
186.25
Fibonacci
169.84
172.26
173.75
176.16
178.58
180.07
182.48
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

AbbVie (0QCV) Moving Averages

Nov 26, 2024, 08:46 PM
Period
Simple
Exponential
MA5
172.26Buy
174.20Buy
MA10
170.73Buy
175.22Buy
MA20
184.43Sell
179.92Sell
MA50
188.62Sell
185.21Sell
MA100
186.79Sell
183.76Sell
MA200
176.51Buy
175.77Buy
AbbVie’s (0QCV) 10-Day exponential moving average is 175.22, while AbbVie’s (0QCV) share price is $177.828, making it a Buy.
AbbVie’s (0QCV) 100-Day exponential moving average is 183.76, while AbbVie’s (0QCV) share price is $177.828, making it a Sell.
AbbVie’s (0QCV) stock price is $177.828 and AbbVie’s (0QCV) 50-day simple moving average is 188.62, creating a Sell signal.
AbbVie’s (0QCV) stock price is $177.828 and AbbVie’s (0QCV) 100-day simple moving average is 186.79, creating a Sell signal.
AbbVie’s (0QCV) stock price is $177.828 and AbbVie’s (0QCV) 200-day simple moving average is 176.51, creating a Buy signal.

AbbVie (0QCV) Technical Indicators

Nov 26, 2024, 08:46 PM
Name
Value
Implied Action
RSI (14)
44.12
Neutral
STOCH (9,6)
66.34
Neutral
STOCHRSI (14)
27.96
Neutral
MACD (12,26)
-5.64
Buy
ADX (14)
28.85
Neutral
Williams %R
-66.79
Buy
CCI (14)
-29.85
Neutral
ATR (14)
4.82
-
Ultimate Oscillator
53.37
Neutral
ROC
-11.86
Sell
AbbVie’s (0QCV) Relative Strength Index (RSI) is 44.12, creating a Neutral signal.
AbbVie’s (0QCV) Trend Strength Indicator (ADX) is 28.85, creating a Neutral signal.
AbbVie’s (0QCV) Commodity Channel Index (CCI) is -29.85, creating a Neutral signal.
AbbVie’s (0QCV) Price Rate of Change (ROC) is -11.86, creating a Sell signal.

FAQ

Is 0QCV a Buy, Hold, or Sell?
Based on 0QCV’s technical indicators, 0QCV is a Hold.
    What is 0QCV’s RSI (14)?
    0QCV’s RSI (14) is 44.12, which suggests 0QCV is a Neutral.
      What is 0QCV’s MACD?
      0QCV’s MACD is -5.64, which suggests 0QCV is a Buy.
        What is 0QCV’s 5-day moving average?
        0QCV’s 5-day moving average is 172.26, which suggests 0QCV is a Buy.
          What is 0QCV’s 20-day moving average?
          0QCV 20-day moving average is 184.43, which suggests 0QCV is a Sell.
            What is 0QCV’s 50-day moving average?
            0QCV’s 50-day moving average is 188.62, which suggests 0QCV is a Sell.
              What is 0QCV’s 200-day moving average?
              0QCV’s 200-day moving average is 176.51, which suggests 0QCV is a Buy.
                What is 0QCV’s Williams % R (14)?
                0QCV’s Williams % R (14) is -66.79, which suggests 0QCV is a Buy.
                  What is 0QCV’s CCI (14)?
                  0QCV’s CCI (14) is -29.85, which suggests 0QCV is a Neutral.
                    What is the share price of AbbVie?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis